The Cancer Drug Fund 1 year on-success or failure?

The Lancet Oncology

Volumn 13, Issue 8, 2012, Pages 754-757

  Stephens, Peter ^a,b   Thomson, David ^c  

^a IQVIA   (United States)

^b UTRECHT UNIVERSITY   (Netherlands)

^c Yorkshire Cancer Network   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CETUXIMAB; EVEROLIMUS; LAPATINIB; SORAFENIB;

CLINICAL PRACTICE; DOSE RESPONSE; DRUG COST; DRUG INFORMATION; FUNDING; HEALTH CARE DISPARITY; HEALTH CARE MANAGEMENT; HEALTH CARE PLANNING; HUMAN; LETTER; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; TREATMENT DURATION; TREATMENT INDICATION;

ANTINEOPLASTIC AGENTS; DRUG COSTS; DRUG UTILIZATION; ENGLAND; FINANCIAL MANAGEMENT; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HEALTHCARE DISPARITIES; HUMANS; ORGANIZATIONAL OBJECTIVES; STATE MEDICINE;

EID: 84864365236     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70273-5     Document Type: Letter

References (8)

1. Keogh B Interim cancer drugs funding: dear colleague letter (accessed June 13, 2012). http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Dearcolleagueletters/DH_117996.
2. £50m kick starts greater access to cancer drugs Department of Health, (accessed June 13, 2012). http://www.dh.gov.uk/en/MediaCentre/Pressreleases/DH_120037.
3. Response to the governments' £50 million Interim Cancer Drugs Fund Cancer Network Pharmacists Forum, (accessed June 13, 2012). http://www.bopawebsite.org/contentimages/publications/Position_Statement_on_CancerDrugFund.pdf.
4. Dehnel T Primary Care Trusts refuse to play NICEly. Lancet Oncol 2012, 13:e7.
5. Hope J Cancer fund betrayal: it promised £200m for vital drugs, but millions haven't been spent-and patients are paying the price (accessed June 13, 2012). http://www.dailymail.co.uk/health/article-2078575/Cancer-Drugs-Fund-Millions-havent-spent-patients-paying-price.html.
6. The Cancer Drugs Fund (CDF)-an overview of progress so far Rarer Cancers Foundation, (accessed June 13, 2012). http://www.rarercancers.org/images/stories/news/0112/cdf_overview_of_numbers_and_treatment_requests_-_december_2011_2.pdf.
7. Richards M Variations in usage of cancer drugs approved by NICE Report of the Review undertaken by the National Cancer Director (accessed June 13, 2012). http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4083895.pdf.
8. Impact assessment of proposal for a Cancer Drug Fund Department of Health, (accessed June 13, 2012). http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_120930.pdf.